Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Etanercept effectively treated a severe skin condition when other treatments failed.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Clofazimine may be effective for treating ashy dermatosis.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Baricitinib may effectively treat nail changes in alopecia areata.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Ritlecitinib can help about 14,000 people with severe hair loss.